Preeclampsia

What Is Preeclampsia?

Preeclampsia is a disease in pregnancy characterized by new onset high blood pressure combined with dysfunction of one or more major organ systems, typically occurring after twenty weeks of gestation.¹

The condition is diagnosed based on blood pressure exceeding one hundred forty over ninety in the second half of pregnancy, combined with evidence of organ involvement.¹

Severe preeclampsia can progress to eclampsia, a condition involving seizures, representing a serious and potentially life threatening complication requiring urgent treatment.²

Preeclampsia is a disease in pregnancy characterized by new-onset hypertension and end-organ dysfunction, often occurring after 20 weeks of gestation.
National Center for Biotechnology Information

Symptoms

Symptoms of preeclampsia include severe headaches, visual disturbances, and altered mental status, all of which warrant prompt medical evaluation during pregnancy.¹

More serious neurologic complications can include uncontrolled vomiting, severe and persistent headache, and in the most serious cases, unexplained seizures, a condition then classified as eclampsia.¹

Because symptoms can develop and progress rapidly, prompt recognition and evaluation of concerning symptoms during pregnancy is critical for maternal and fetal safety.

Causes

Severe preeclampsia appears to involve a state of increased seizure susceptibility resulting from disruption of the blood brain barrier and associated neuroinflammation.²

This disruption of normal protective brain barriers helps explain why severe preeclampsia carries meaningful neurologic risk, extending well beyond blood pressure elevation alone.²

The precise underlying mechanisms driving preeclampsia remain an active area of ongoing research, though placental factors and abnormal blood vessel development are believed to play a central role.³

Risk Factors

Recognized risk factors for preeclampsia include a prior history of the condition, diabetes, kidney disease, obesity, and advanced maternal age at the time of pregnancy.¹

Women with any of these risk factors benefit from closer monitoring throughout pregnancy, supporting earlier identification if preeclampsia begins to develop.

Understanding individual risk profile allows healthcare providers to implement more targeted surveillance strategies for women at elevated risk of developing the condition.

Complications

Without appropriate treatment, preeclampsia can progress to eclampsia, involving seizures, and in the most severe cases, coma and death for the mother.¹

The only definitively curative treatment for preeclampsia is termination of the pregnancy itself, through either induced delivery or cesarean section, reflecting the condition’s fundamental connection to ongoing pregnancy.³

This reality creates a genuinely difficult clinical balance between maternal safety and fetal maturity, particularly when preeclampsia develops well before full term.³

Treatment

Current clinical management includes blood pressure lowering medications such as hydralazine and labetalol, alongside magnesium sulfate to slow disease progression and prevent maternal seizures.³

Magnesium sulfate remains the most widely used anticonvulsant medication for treating patients with preeclampsia and eclampsia, working by opposing calcium dependent arterial constriction to relieve vasospasm.⁴

Magnesium may also help prevent cell damage by counteracting the increase in intracellular calcium concentration caused by reduced blood flow, offering protective benefit at the cellular level.⁴

Prevention

While preeclampsia cannot always be entirely prevented, appropriate prenatal care and monitoring support earlier identification and management of the condition.

Women with identified risk factors may benefit from specific preventive interventions discussed with their healthcare provider, tailored to their individual risk profile.¹

Because magnesium sulfate carries its own risk of toxicity, careful dosing and monitoring remain essential parts of safe preeclampsia treatment, requiring close clinical oversight.⁵

Why Visual Communication Matters for Preeclampsia

Explaining how disrupted blood vessel function during pregnancy can affect multiple organ systems simultaneously requires visuals that make this complex, potentially serious condition understandable to expectant mothers.

Pharmaceutical companies, obstetric practices, and patient education organizations rely on precise illustration and animation to explain preeclampsia diagnosis and treatment.

• Illustrating blood pressure regulation and organ system involvement in preeclampsia
• Animating the mechanism of action of magnesium sulfate treatment
• Explaining the progression from preeclampsia to eclampsia
• Visualizing blood brain barrier disruption and neurologic risk
• Supporting patient education on warning signs requiring urgent care
• Creating training materials for obstetric clinicians

How Biotic Artlab Supports Preeclampsia Communication

We work with pharmaceutical companies, obstetric practices, and healthcare organizations to create scientifically accurate visuals that make preeclampsia easier to understand.

• Custom 3D animations of blood pressure regulation and organ involvement
• Detailed illustrations of magnesium sulfate mechanism of action
• Visualizations of disease progression from preeclampsia to eclampsia
• Patient facing materials on warning signs and when to seek care
• Clinical training content for obstetric teams
• Conference presentations and marketing visuals for maternal health audiences

Frequently Asked Questions

What is preeclampsia?

It is a pregnancy condition involving new onset high blood pressure and organ dysfunction, typically after twenty weeks of gestation.¹

What are the warning symptoms of preeclampsia?

Severe headache, visual disturbances, and altered mental status are important warning symptoms.¹

What is eclampsia?

It is a severe complication of preeclampsia involving seizures, requiring urgent treatment.¹

What are the main risk factors for preeclampsia?

Prior preeclampsia, diabetes, kidney disease, obesity, and advanced maternal age are recognized risk factors.¹

What is the only curative treatment for preeclampsia?

Delivery of the baby, through induction or cesarean section, is the only definitively curative treatment.³

What is magnesium sulfate used for?

It is used to prevent seizures and slow disease progression in preeclampsia and eclampsia.⁴

Have a Project in Mind? Contact Us.

If you are developing patient education materials, clinical training content, or marketing visuals related to preeclampsia, our team can help translate the science into visuals that are both accurate and easy to understand. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.

References

1. National Center for Biotechnology Information. Eclampsia.
2. National Center for Biotechnology Information. Magnesium Sulfate Treatment Reverses Seizure Susceptibility and Decreases Neuroinflammation in a Rat Model of Severe Preeclampsia.
3. National Center for Biotechnology Information. The Management of Preeclampsia, A Comprehensive Review of Current Practices and Future Directions.
4. National Center for Biotechnology Information. Action of Magnesium Sulfate in the Treatment of Preeclampsia-Eclampsia.
5. National Center for Biotechnology Information. An Integrative Review of the Side Effects Related to the Use of Magnesium Sulfate for Pre-eclampsia and Eclampsia Management.

Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, or individualized advice from a qualified healthcare professional.